This inventor holds 1 USPTO granted patent. Top assignee: Children's Medical Center Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovations of Andrew Doxey
Introduction
Andrew Doxey is a notable inventor based in Waterloo, Canada. He has made significant contributions to the field of neurotoxin research, particularly with his work on a novel homolog of neurotoxin (BoNT) identified in the bacterial species BoNT/EN. His innovative approach has opened new avenues for therapeutic applications.
Latest Patents
Andrew Doxey holds 1 patent for his work on neurotoxin (BoNT/EN) and its derivatives. This patent includes variants and chimeric toxins that comprise domains from BoNT/EN and other BoNTs. The methods of producing BoNT/EN and its potential uses in therapeutic applications are also detailed in his patent.
Career Highlights
Doxey is affiliated with the Children's Medical Center Corporation, where he continues to advance his research. His work has garnered attention for its potential impact on medical treatments and therapies.
Collaborations
Throughout his career, Andrew has collaborated with esteemed colleagues such as Min Dong and Sicai Zhang. These partnerships have contributed to the depth and breadth of his research.
Conclusion
Andrew Doxey's innovative work in neurotoxin research exemplifies the potential of scientific advancements in therapeutic applications. His contributions are paving the way for future developments in the field.